{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:42:43Z","timestamp":1790293363235,"version":"4.1.0"},"reference-count":44,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"491","funder":[{"DOI":"10.13039\/100007013","name":"F. Hoffmann-La Roche Ltd.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007013","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. Transl. Med."],"published-print":{"date-parts":[[2019,5,8]]},"abstract":"<jats:p>In the VANILLA phase 2 clinical trial, balovaptan treatment resulted in improved adaptive behaviors in adult men with autism.<\/jats:p>","DOI":"10.1126\/scitranslmed.aat7838","type":"journal-article","created":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T23:34:31Z","timestamp":1556753671000},"source":"Crossref","is-referenced-by-count":118,"title":["A phase 2 clinical trial of a vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorder"],"prefix":"10.1126","volume":"11","author":[{"given":"Federico","family":"Bolognani","sequence":"first","affiliation":[{"name":"Neuroscience, Ophthalmology, and Rare Diseases (NORD), Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Basel, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"del Valle Rubido","sequence":"additional","affiliation":[{"name":"Neuroscience, Ophthalmology, and Rare Diseases (NORD), Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Basel, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Squassante","sequence":"additional","affiliation":[{"name":"Product Development, F. Hoffmann\u2013La Roche AG, Basel, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Wandel","sequence":"additional","affiliation":[{"name":"Product Development, F. Hoffmann\u2013La Roche AG, Basel, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Derks","sequence":"additional","affiliation":[{"name":"Roche Pharma Research and Early Development, Roche Innovation Center Welwyn, Roche Products Ltd., Welwyn, UK."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"Murtagh","sequence":"additional","affiliation":[{"name":"Neuroscience, Ophthalmology, and Rare Diseases (NORD), Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Basel, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0974-6434","authenticated-orcid":true,"given":"Jeff","family":"Sevigny","sequence":"additional","affiliation":[{"name":"Neuroscience, Ophthalmology, and Rare Diseases (NORD), Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Basel, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Khwaja","sequence":"additional","affiliation":[{"name":"Neuroscience, Ophthalmology, and Rare Diseases (NORD), Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Basel, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Umbricht","sequence":"additional","affiliation":[{"name":"Neuroscience, Ophthalmology, and Rare Diseases (NORD), Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann\u2013La Roche Ltd., Basel, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3883-257X","authenticated-orcid":true,"given":"Paulo","family":"Fontoura","sequence":"additional","affiliation":[{"name":"Product Development, F. Hoffmann\u2013La Roche AG, Basel, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders (5th ed.) (American Psychiatric Association Publishing 2013).","DOI":"10.1176\/appi.books.9780890425596"},{"key":"e_1_3_2_3_2","first-page":"1","article-title":"Estimated prevalence of autism and other developmental disabilities following questionnaire changes in the 2014 National Health Interview Survey","volume":"87","author":"Zablotsky B.","year":"2015","unstructured":"B. Zablotsky, L. I. Black, M. J. Maenner, L. A. Schieve, S. J. Blumberg, Estimated prevalence of autism and other developmental disabilities following questionnaire changes in the 2014 National Health Interview Survey. Natl. Health Stat. Rep. 87, 1\u201320 (2015).","journal-title":"Natl. Health Stat. Rep."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.ss6706a1"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.115.174649"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-2362"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1177\/070674371205700502"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/aur.1848"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/mpr.1466"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1177\/1362361314542955"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2010.03.005"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yhbeh.2011.10.007"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31828cfb15"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2012.09.025"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2006.08.040"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2011.07.013"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2013.09.022"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4530(02)00133-6"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0600406103"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2010.03.014"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2008.54"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yhbeh.2011.12.014"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.2270"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300518"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037313"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2016.232"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm501745f"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","unstructured":"S. S. Sparrow D. V. Cicchetti D. A. Balla Vineland-II Adaptive Behavior Scales Survey Forms Manual (PsychCorp Bloomington ed. 2 2005).","DOI":"10.1037\/t15164-000"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/aur.1874"},{"key":"e_1_3_2_30_2","unstructured":"European Medicines Agency Guideline on the clinical development of medicinal products for the treatment of Autism Spectrum Disorder (ASD) (EMA\/CHMP\/598082\/2013 2017); www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2017\/11\/WC500238886.pdf."},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2016.237"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aab4109"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2017.177"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2015.0146"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/jcpp.12305"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awv249"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2015.162"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1705521114"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2018.00027"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa8120"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2013.3181"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.152"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1186\/2040-2392-3-16"},{"key":"e_1_3_2_44_2","article-title":"Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: A randomized clinical trial","author":"Yamasue H.","year":"2018","unstructured":"H. Yamasue, T. Okada, T. Munesue, M. Kuroda, T. Fujioka, Y. Uno, K. Matsumoto, H. Kuwabara, D. Mori, Y. Okamoto, Y. Yoshimura, Y. Kawakubo, Y. Arioka, M. Kojima, T. Yuhi, K. Owada, W. Yassin, I. Kushima, S. Benner, N. Ogawa, Y. Eriguchi, N. Kawano, Y. Uemura, M. Yamamoto, Y. Kano, K. Kasai, H. Higashida, N. Ozaki, H. Kosaka, Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: A randomized clinical trial. Mol. Psychiatry 10.1038\/s41380-018-0097-2 (2018).","journal-title":"Mol. Psychiatry"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau7356"}],"container-title":["Science Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1126\/scitranslmed.aat7838","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/scitranslmed.aat7838","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T18:46:14Z","timestamp":1705430774000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/scitranslmed.aat7838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,8]]},"references-count":44,"journal-issue":{"issue":"491","published-print":{"date-parts":[[2019,5,8]]}},"alternative-id":["10.1126\/scitranslmed.aat7838"],"URL":"https:\/\/doi.org\/10.1126\/scitranslmed.aat7838","relation":{},"ISSN":["1946-6234","1946-6242"],"issn-type":[{"value":"1946-6234","type":"print"},{"value":"1946-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,8]]},"article-number":"eaat7838"}}